ALTO NEUROSCIENCE INC

ANRO · NYSE

Updated at 2026-10-15 09:38:55

$21.71-1.72%
Today's High
$22.59
Today’s Low
$21.32
ALTO NEUROSCIENCE INC (ANRO) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$21.83
Previous Close
$21.71
Volume
2.28M
Market Cap
$851.94M
P/E Ratio
--
EPS
$-2.43

Previous Day Range

$21.32$22.59

52-Week Range

$5.22$37.48

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
BIOTECHNOLOGY
Headquarters
650 CASTRO STREET, MOUNTAIN VIEW, CA, UNITED STATES, 94041
Country
US
Listing Date
2024-02-02
Fiscal Year End
September
Shares Outstanding
38.83M
CIK
0001999480

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos, California.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

2025-09-30

$0

Operating Expenses

2026-06-30

$29.12M

2026-03-31

$26.95M

2025-12-31

-$115.67M

2025-09-30

$14.95M

Net Income

2026-06-30

-$27.63M

2026-03-31

-$26.23M

2025-12-31

-$16.18M

2025-09-30

-$14.18M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.65

2026-03-31

$-0.80

2025-12-31

$-0.45

2025-09-30

$-0.52

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$26.96M

2026-03-31

-$25.5M

2025-12-31

-$15.45M

2025-09-30

-$13.36M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.